Navamedic ASA (FRA:N1A)

Navamedic ASA Statistics

Total Valuation

Navamedic ASA has a market cap or net worth of EUR 45.43 million. The enterprise value is 67.51 million.

Market Cap	45.43M
Enterprise Value	67.51M

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	23.98M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.09%
Owned by Institutions (%)	52.70%
Float	21.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	52.17
PS Ratio	0.99
PB Ratio	2.54
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	36.33
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 24.59, with an EV/FCF ratio of -4.53.

EV / Earnings	-20.88
EV / Sales	1.47
EV / EBITDA	24.59
EV / EBIT	74.12
EV / FCF	-4.53

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 1.49.

Current Ratio	1.49
Quick Ratio	0.72
Debt / Equity	1.49
Debt / EBITDA	9.64
Debt / FCF	-1.78
Interest Coverage	0.55

Financial Efficiency

Return on equity (ROE) is -15.99% and return on invested capital (ROIC) is 1.47%.

Return on Equity (ROE)	-15.99%
Return on Assets (ROA)	1.08%
Return on Invested Capital (ROIC)	1.47%
Return on Capital Employed (ROCE)	1.94%
Revenue Per Employee	1.10M
Profits Per Employee	-76,984
Employee Count	42
Asset Turnover	0.87
Inventory Turnover	3.30

Taxes

In the past 12 months, Navamedic ASA has paid 289,618 in taxes.

Income Tax	289,618
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -18.75% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-18.75%
50-Day Moving Average	1.83
200-Day Moving Average	1.84
Relative Strength Index (RSI)	45.18
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Navamedic ASA had revenue of EUR 46.03 million and -3.23 million in losses.

Revenue	46.03M
Gross Profit	16.89M
Operating Income	914,933
Pretax Income	-2.94M
Net Income	-3.23M
EBITDA	2.49M
EBIT	914,933
Earnings Per Share (EPS)	n/a

Balance Sheet

The company has 4.41 million in cash and 26.59 million in debt, giving a net cash position of -22.18 million.

Cash & Cash Equivalents	4.41M
Total Debt	26.59M
Net Cash	-22.18M
Net Cash Per Share	n/a
Equity (Book Value)	17.89M
Book Value Per Share	n/a
Working Capital	6.65M

Cash Flow

In the last 12 months, operating cash flow was 1.25 million and capital expenditures -16.16 million, giving a free cash flow of -14.91 million.

Operating Cash Flow	1.25M
Capital Expenditures	-16.16M
Free Cash Flow	-14.91M
FCF Per Share	n/a

Margins

Gross margin is 36.70%, with operating and profit margins of 1.99% and -7.02%.

Gross Margin	36.70%
Operating Margin	1.99%
Pretax Margin	-6.40%
Profit Margin	-7.02%
EBITDA Margin	5.42%
EBIT Margin	1.99%
FCF Margin	n/a

Dividends & Yields

Navamedic ASA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.12%
FCF Yield	-32.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3